Código SA para parches transdérmicos

EU Binding Tariff Information

HS Code :
HS Code :

BTI Reference :

Issuing Country : UNITED KINGDOM

Date Of Issue : 08.Jul.2011 - 07.Jul.2017

CLONIDINE HYDROCHLORIDE MEDICAMENT

Description : MEDICAMENT.CLONIDINE HYDROCHLORIDE FORM: TRANSDERMAL PATCH PACK PUT UP IN MEASURED DOSES 1X4, 4 SYSTEMS AND 4 ADHESIVE COVERS.EACH SYSTEM CONTAINS 5.0 MG OF CLONIDINE. INACTIVE COMPONENTS AREMINERAL OIL, POLYISOBUTYLENE, COLLOIDAL SILICON DIOXIDE, POLYPROPYLENE AND PIGMENTED POLYESTER FILMS. FOR THERAPUTIC USE.FOR THE TREATMENT OF THE CARDIOVASCULAR SYSTEM (HYPERTENSION). THE ACTIVE INGREDIENT IS CLONIDINE.

Source : EU Binding Tariff Information
source link :

US Customs Ruling (CROSS)

HS Code :
HTS Code :

Ruling Number :

Issuing Country : UNITED STATES

Date Of Issue : 2019-12-19T00:00:00

Rivastigmine Transdermal System in dosage form

Rivastigmine Transdermal System is a medicinal preparation containing Rivastigmine, a cholinesterase inhibitor, as the active ingredient. It is indicated for the treatment of dementia of the Alzheimer’s type (AD)

Rivastigmine Transdermal System is a medicinal preparation containing Rivastigmine, a cholinesterase inhibitor, as the active ingredient. It is indicated for the treatment of dementia of the Alzheimer’s type (AD) and will be imported in dosages of 4.6 mg, 9.5 mg and 13.3 mg transdermal patches applied to the skin.

Description : Rivastigmine Transdermal System in dosage form

Source : US Customs Ruling (CROSS)
source link :